Fosun Pharma chairman proposes A-share buyback of 250m to 500m yuan
复星医药:董事长陈玉卿提议公司以集中竞价方式回购A股,回购资金总额不低于2.5亿元且不超过5亿元,回购价格不超过董事会通过回购方案决议前30个交易日均价的150
It is a proposal so far; the board still has to approve the plan.
Fosun Pharma chairman Chen Yuqing has proposed that the company buy back A-shares through centralised bidding for 250m to 500m yuan, at no more than 150% of the average price over the 30 trading days before the board approves the plan, the company said. The buyback would run for up to 12 months, and the shares would be used for convertible-bond conversion, equity incentives and/or an employee share plan.